More stories

  • in

    Visceral Fat Over Weight Loss; BP Control Incentive Backfires; PVCs Not Benign

    Source link : https://newshealth.biz/health-news/visceral-fat-over-weight-loss-bp-control-incentive-backfires-pvcs-not-benign/ Losing visceral fat by diet and exercise — regardless of pounds shed or later regained — was tied to long-term improvements in cardiometabolic health, follow-up data from two randomized trials showed. (Circulation) A study suggested that one gut microbial species has the potential to relieve cardiotoxicity associated with microplastics exposure. (Circulation) The FDA cleared the […] […] More

  • in

    Ebola Webinar June 4: Former USAID Official Discusses Flawed U.S. Response

    Source link : https://newshealth.biz/health-news/ebola-webinar-june-4-former-usaid-official-discusses-flawed-u-s-response/ The Trump administration moved quickly to dismantle the U.S. Agency for International Development (USAID) after taking office in early 2025, implementing a funding freeze, issuing stop-work orders, and carrying out mass layoffs. At the time, the global public health community warned that such actions could have significant short- and long-term consequences affecting millions globally. Now, […] […] More

  • in

    Melanoma Vaccine Halves Risk of Recurrence, Metastasis Over 5 Years

    Source link : https://newshealth.biz/health-news/melanoma-vaccine-halves-risk-of-recurrence-metastasis-over-5-years/ CHICAGO — An investigational individualized vaccine for surgically resected melanoma demonstrated durable benefits in reducing the risks of recurrence and distant spread, 5-year follow-up of a randomized study showed. Adding the mRNA vaccine intismeran autogene to pembrolizumab (Keytruda) in resected stage IIIB-IV melanoma cut the risk of recurrence or death by 49% (HR 0.51, 95% […] […] More

  • in

    Step forward drug just about doubles survival with complex pancreatic most cancers – an oncologist explains how daraxonrasib overcame an ‘undruggable’ illness

    Source link : https://health365.info/step-forward-drug-just-about-doubles-survival-with-complex-pancreatic-most-cancers-an-oncologist-explains-how-daraxonrasib-overcame-an-undruggable-illness/ For a very long time, the possibility of surviving pancreatic most cancers has been extraordinarily low. For sufferers who had been identified with metastatic pancreatic most cancers between 2015 and 2021, about 97% died inside of 5 years in their prognosis. Pancreatic most cancers is so fatal partly as a result of there aren’t any efficient […] More

  • in

    MHRA Authorises Rilzabrutinib for Adult ITP

    Source link : https://newshealth.biz/health-news/mhra-authorises-rilzabrutinib-for-adult-itp/ The MHRA has authorised rilzabrutinib for adults with ITP where prior therapies have failed, based on phase 3 data showing durable platelet response. Medscape News UK Source link : https://www.medscape.com/viewarticle/mhra-authorises-rilzabrutinib-adult-itp-2026a1000ibk?src=rss Author : Publish date : 2026-06-02 17:43:00 Copyright for syndicated content belongs to the linked Source. The post MHRA Authorises Rilzabrutinib for Adult ITP first appeared […] More

  • in

    Novel theranostic way objectives competitive neuroendocrine prostate most cancers

    Source link : https://health365.info/novel-theranostic-way-objectives-competitive-neuroendocrine-prostate-most-cancers/ A singular theranostic way that objectives RET — a newly known biomarker for neuroendocrine prostate most cancers allows high-contrast PET imaging and efficient, secure medication for this extremely competitive malignancy. As a result of this illness is ceaselessly poorly visualized with prostate-specific membrane antigen (PSMA)-based imaging, the RET way provides crucial choice when standard molecular imaging and PSMA-directed […] More

  • in

    Docs Should Compete for Patient Dollars, Not Political Influence, Economist Says

    Source link : https://newshealth.biz/health-news/docs-should-compete-for-patient-dollars-not-political-influence-economist-says/ In this series, MedPage Today is asking healthcare economists and policy experts the same questions about the high costs of U.S. healthcare. They’ll discuss what they believe is working, what’s not working, and what else can be done to bring costs down. In this interview, Brian Blase, PhD, founder and president of Paragon Health Institute […] […] More

  • in

    People Are Booing AI. Health Leaders Should Take Note.

    Source link : https://newshealth.biz/health-news/people-are-booing-ai-health-leaders-should-take-note/ The post People Are Booing AI. Health Leaders Should Take Note. first appeared on News Health. —- Author : News Health Publish date : 2026-06-02 16:37:00 Copyright for syndicated content belongs to the linked Source. —- 1 – 2 – 3 – 4 – 5 – 6 – 7 – 8 More

  • in

    Home Cardiac Rehab Data Signal Wider Access Gains

    Source link : https://newshealth.biz/health-news/home-cardiac-rehab-data-signal-wider-access-gains/ Home-based digital cardiac rehab platforms are reaching women, ethnic minorities, and deprived communities missed by conventional services, new data show. Medscape News UK Source link : https://www.medscape.com/viewarticle/home-cardiac-rehab-data-signal-wider-access-gains-2026a1000ict?src=rss Author : Publish date : 2026-06-02 14:54:00 Copyright for syndicated content belongs to the linked Source. The post Home Cardiac Rehab Data Signal Wider Access Gains first appeared on […] More

  • in

    More Data Support Trodelvy-Keytruda Combo in Triple-Negative Breast Cancer

    Source link : https://newshealth.biz/health-news/more-data-support-trodelvy-keytruda-combo-in-triple-negative-breast-cancer/ CHICAGO — Sacituzumab govitecan (SG, Trodelvy) added to pembrolizumab (Keytruda) extended a surrogate measure of long-term clinical outcomes compared with chemotherapy plus pembrolizumab in patients with PD-L1-positive metastatic triple negative breast cancer (mTNBC), according to an analysis of the phase III ASCENT-04 trial. Median progression-free survival after the next line of treatment (PFS2) was not […] […] More

  • in

    Prescription Drug Monitoring Programs Shape Care. Our Patients Should Know.

    Source link : https://newshealth.biz/health-news/prescription-drug-monitoring-programs-shape-care-our-patients-should-know/ For many patients, taking a controlled medication feels like any ordinary medical decision. You’re prescribed something for sleep, anxiety, ADHD, or pain. You’re counseled on risks and side effects. You pick it up from the pharmacy and assume the transaction ends there. What patients are not routinely told is that once that prescription is filled, […] […] More

  • in

    More black men to benefit from prostate cancer screening trial

    Source link : https://newshealth.biz/health-news/more-black-men-to-benefit-from-prostate-cancer-screening-trial/ Experts are trying to find the best way to screen for prostate cancer, since blood tests alone are not accurate enough for most men. Source link : https://www.bbc.com/news/articles/c4g91jrl349o?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-06-02 14:52:00 Copyright for syndicated content belongs to the linked Source. The post More black men to benefit from prostate cancer screening trial […] More

Load More
Congratulations. You've reached the end of the internet.